Comparison of risperidone, olanzapine and quetiapine: effects on body weight, serum blood glucose and prolactin

Abstract

Schizophrenia is a chronic illness with a lifetime prevalence of 1% and with serious physical, social and economic consequences. Over the past decade, atypical antipsychotic medications have become the first-line treatment for schizophrenia (Breier et al, 2005).